Home » PNB Genetics News & Research » 23andMe: The Ethics of Genetic Testing for Neurodegenerative Diseases

23andMe: The Ethics of Genetic Testing for Neurodegenerative Diseases

By Liana Meffert
The Neuroethics Blog
June 2, 2015

“The face of genetic testing and counseling is in the midst of a major overhaul. Historically, a patient had to demonstrate several risk factors including familial and medical health history or early symptoms in order to be tested for the likelihood of developing a neurodegenerative disease. For the first time, the public has unrestricted and unregulated access to the relative probability of developing certain neurodegenerative diseases…”

Click here for full story